ABH glycosyltransferase levels in sera and red cell membranes from Hz and Hm variant bloods  by Mulet, C. et al.
Volume 90, number 2 FEBSLETTERS June 1978 
ABH GLYCOSYLTRANSFERASE LEVELS IN SERA AND RED CELL MEMBRANES 
FROM Hz AND Hm VARIANT BLOODS 
C. MULET, J. P. CARTRON, M. LOPEZ and Ch. SALMON 
Groupe U 76 De Recherches de L !INSERMet Centre National de 112ansfusion Sanguine, 6 Rue Alexandre Gzbanel, 
75 739 Paris Ckdex 15, France 
Received 28 March 1978 
Revised version received 19 April 1978 
1. Introduction 
The A and B blood group antigens of human fluids 
and tissues are carbohydrate structures attached to 
glycoproteins or glycolipids [ 1,2] . These substances 
are built up by A and B gene specified glycosyltrans- 
ferases acting on appropriate H precursors which all 
exhibit the terminal disaccharide structure: 
cw-LFuc( 1+2) Gal-R [3] . 
A and B enzymes catalyse the addition of 
&N-acetyl-D-galactosamine and a-D-galactose 
respectively on the carbon 3 position of the non- 
reducing /3-D-galactose of H substrates [3] . 
The production of H substance is under the control 
of a genetic system, unrelated to Al30 locus, termed 
Hh. The latter is characterized by an highly frequent 
allele H, producing the cY_2-L-fucosyltransferase 
[4,5] and by a very rare allele h, considered to be an 
amorph [6,7]. Indeed the H enzyme has not been 
found either in sera and in RBC membranes from 
‘Bombay’ (Off, Ot) thought to be homozygous for 
the recessive h gene, nor in ‘Parabombay’ (Ah, Bh) 
individuals which may arise from poorly active gene 
at the Hh locus [5,8,12] . However, the A and/or B 
enzymes are normally expressed among such 
individuals, but are unable to fulfil their catalytic 
function due to the lack of H reactive structures. It 
is generally admitted that the complete expression 
of H substance is controlled by two other genetic 
systems. 
(i) The secretor system Sese, which appears as a 
regulator of H enzyme synthesis at the site of H 
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glycoprotein production. Indeed, the H enzyme 
is not found in milk or submaxillary glands 
from non-secretors sese [4,5]. However, the 
H enzyme is found in sera and bone marrow 
from both secretors Se and non-secretor sese 
which suggest hat the enzyme is produced in 
numerous cells and later on poured into the blood 
stream [5,10,13]. The direct product of the Se 
gerfe is unknown. 
(ii) The Zz system has been postulated in order to 
explain some rare H variants characterized by a 
selective deficiency of H antigen on red cells but 
normal expression of H substance in saliva [ 14,161. 
It is assumed that the Zz system regulates H 
enzyme synthesis at the site of H glycolipid 
production, at least in erythroblasts. By analogy 
with Am phenotypes, such variants have been 
named Hm phenotypes. 
The most common form of Hm phenotypes is 
inherited as a recessive character in individuals with a 
combination of two z genes [ 161. Three families in 
which the Hm phenotypes were inherited as a 
dominant trait have been described, suggesting the 
occurence of a dominant allele Zm at the Zz locus 
[l&18]. 
Accordingly, following our studies on H variants 
[ 121 it was of interest to determine if the ar-2-Lfuco- 
syltransferase is normally active in sera and RBC 
membrane from Hm bloods, both of the recessive 
and dominant inheritances. 
233 
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2. Materials and methods 
The H variants from 6 unrelated families were 
collected. Red cells and sera were stored at -20°C 
until used. Hm samples from Trn. and Jur. families 
were collected in Czechoslovakia and kindly sent 
by Dr Hrubisko (Bratislavia). Among French samples, 
the Let. family sample originates from Dr Kling 
(Metz), Dup. family and Bon. sample from 
Dr Jouvenceaux (Lyon) and Thi. from our unit. 
UDP-D-[ r4C]galactose (274 mCi/mmol) was 
obtained from Nen Chemicals (Frankfurt) and 
p-nitrophenyl-N-acetylg-D_glucosamine from Koch- 
Light (London). 
Reagents and methods used to estimate A, B and 
H glycosyltransferases in era and RBC membranes 
have been described [ 12,19,20] . The level of UDPGal: 
GWAc-/l4-D-galactosyltransferase was stimated in 
RBC membranes by adding the following components 
in total vol. 17.5 ~1: 100-200 I-(g erythrocyte mem- 
brane protein; sodium cacodylate buffer pH 7.0, 
4 pmol; MnC12, 2pmol; p-nitrophenyl#-acetyl-D- 
glucosamine, 0.25 I.tmol; UDP-D-[ 14C]galactose, 
0.65 nmol; 10 ~1 Triton X-100 5% (v/v). The mixture 
was incubated for 18 h at 37°C and the reaction 
product isolated by single-step chromatography in 
ethylacetate-pyridine-water (10 : 4 : 3). The eluted 
radioactive p-nitrophenyl-N-acetyl-D-galactosamine 
released 100% of D-[14C]galactose following degra- 
dation (48 h at 37’C) by a Jack bean galactosidase 
specific of galactose p-(1+4) linked [21]. 
3. Results and discussion 
By definition, Hm individuals are characterized 
by a selective decrease of H antigen on their RBC and 
normal amount of H substance in saliva [14,161. For 
reasons which will appear later, we have subdivised 
these H variants in two categories as refered to ‘Hz’ 
and ‘Hm’. These phenotypes are inherited as recessive 
or dominant raits [22], respectively. 
3.1. First type of H variants (Hz phenotypes) 
Nine blood samples with H negative RBC and 
normal H secretory saliva were studied in 4 unrelated 
families (Dup., Trn., Thi., Bon.). 
The recessive mode of inheritance of the Hz 
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character in Dup. family is shown in fig.la. As 
previously demonstrated with ‘Bombay’ samples 
[5,8,12] the H enzyme is absent or catalytically 
inactive in sera and RBC membranes from all these 
Hz individuals (table 1). However, the A and/or B 
enzyme levels fall in the normal range, which confirm 
the true genotypes deduced from family studies. Very 
clearly, in spite of common features with ‘Bombay’ 
bloods, the Hz cannot be explained by the inheritance 
of a double dose of h gene because their saliva con- 
tains a normal amount of H substance. The lack of 
a-2-Lfucosyltransferase activity in Hz sera, suggests 
that the serum enzyme does not originate from 
secretory organs till able to produce H substance. 
Moreover, this assumption isconsistent with the 
similar level of H enzyme which have been found in 
secretor and non-secretor sera [lo] . It was noticed 
I 
Fig.la 
Fig.lb 
Fig.1. Genealogy of typical Hz and Hm families. F&la. Pedi- 
gree of Dup.family. F&lb. Pedigree of Let. family. Symbols: 
(0, n ) Hz or Hm variants; (8) atypical H variant. 
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Table 1 
ABH glycosyltransferases levels in sera and RBC ghosts from Hz variants 
Sample Genotype In serum In RBC ghosts 
A, A2 B H A B H 
(PH 6 .O) (PH 7.0) 
Dup. n o;z 
m %z 
e o:z 
0 0 
0 0 
0 0 
Trn. h Oiz 
a +z 
m 
“B” OHz Jc 
jb $z 
0 
12 900 0 35 900 0 
13 400 0 
23 000 0 
13 600 0 
Thi. a okz 0 0 
Bon. OA1 Hz 28 900 20 800 0 51300a 0 
Controls 0 7040 (14) 4310 (4) 
A, 28 000 (16) 9380 (16) 21 260 (6) 5170 (3) 
A, 16 420 (17) 8490 ;17) 2655 (5) 6020 (3) 
A,B 25 370 (14) 11480 (14) 9100 (17) 52 93; (2) 31 720 (2) 4350 (2) 
A,B 12 750 (16) 8250 (16) 6445 (16) 
A, A, 29 200 (9) 24 550 (9) 11 390 (10) 8400 (1) 
BI 5820 (10) 6310 (10) 51 530 (6) 8000 (7) 
BII 12 300 (10) 4880 (10) 
a This activity falls in the normal range of controls. Indeed, only mean values have been reported for control samples 
in which large individual variations of A and B enzymes in ,RBC have been noticed 
Serum enzyme activities are expressed as cpm of radioactive sugar donor incorporated by serum in standard assay conditions 
[ 12,201. In RBC ghosts the enzyme levels are calculated in cpm/mg protein. Zero values mean no detectable enzyme 
activity 
that Hz bloods II-l, II4 and 116 from the Dup. 
family (tig.la) were grouped Le(a-b+) on their 
erythrocytes but gave negative reactions with anti-H 
reagents. This observation is a further demonstration 
that Lewis substances are not synthesized by RBC 
but rather passively acquired from plasma [23,24] . 
The Lewis antigens taken up by Hz RBC are glyco- 
sphingolipids of unknown origin where obviously 
the expression of H is not suppressed. Then, if Hz 
phenotypes occur by action of the hypothetical Zz 
system, these individuals have at least one copy of 
Se and H genes and a double dose of z gene. 
Tl% behavior of the z gene does not appear as a 
general switch of H glycolipid production, but rather 
as a more specific regulator of H glycolipid substance 
of RBC. It is suggested that if most of the serum 
enzyme originates from red cells, the genetic block 
caused by zz genes in Hz individuals fully explains 
the absence of cr-2-Lfucosyltransferase, both in their 
sera and RBC membranes. However, the identification 
235 
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of A,, variants [141 also provides evidence that the 
H gene of these individuals i  not completely silent. 
Finally, as mentioned above, the terminology Hz 
seems more appropriate for such H variants. 
3.2. Second type of H variants (Hm phenotypes) 
The Dup. family: 
In the Jur. family investigated atthe present ime, 
the trait is inherited accross 3 generations but, on 
the contrary, of the recessive Hz variants tudied 
above, the H antigen of Jur.‘s RBC is only partly 
reduced when tested with anti-H reagents from 
Ulex europaeus and Labumum alpinum [ 17,181. 
When the sera from 2 AHm and 4 A,, B individuals 
were examined, astrong a-2-L-fucosyltransferase 
activity was found (table 2). Moreover, the sera from 
A,, B people had a normal B transferase l vel and in 
all cases A transferase from A,, and A,, B had an 
optimum activity at about pH 7.0-7.5, which is 
characteristic of A2 enzyme [25] . The RBC mem- 
branes of Jur. samples have not been tested, because 
only minute amounts of erythrocytes were available. 
However, from the results presented below it is very 
likely that A, B and H transferases are present in 
these red cells. 
It is impossible from our data to speculate if the 
slightly reduced content of H antigen in Jur.‘s RBC 
is due to a ‘dominant’ modifier or more simply to 
some allele at the Hh locus. According to [ 181 the H 
defect caused by a regulatory mechanism, isonly 
effective in ‘cis position’ with respect of A gene. 
Indeed, the A antigen from A,, and AHm B is also 
slightly reduced while a normal B antigen strength 
has been demonstrated in the latter. Alternatively, 
we suggest that a competition between A and B 
transferase for the precursor, may also explain these 
serological data. 
The Let. family: 
A second family (Let.) where the character is 
inherited in 3 generations i  shown in fig.1 b. 
Erythrocytes from the father II-2 are also H defective, 
but he was found to be a non-secretor. Nevertheless, 
no history of consanguinity could be demonstrated 
between II-2 and 11-3. Au children from this mating 
have H deficient RBC, some being secretors (1114, 
111-5) and others non-secretors (III-l, III-2,1113). 
Among the 3 children from 114,2 are of the Hm type 
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(III-6 and 111-8) and 1 is a normal group 0 (111-j). 
The H red cell antigenic strength from members 
of Let. family is shown in table 2. The defect of H 
was more pronounced among A than among 0 
individuals, and it was noticed that most H variants 
of group A had a decreased expression of A, antigen. 
Such individuals were hardly discernable from AZ 
people. 
Investigations of A and H transferases in sera and 
RBC from members of the Let. family (table 2) can 
be summarized as follow: 
(i) The H serum enzyme activities fall in normal 
range as compared to common ABO blood 
samples. 
(ii) Despite a significant drop of their H antigen, the 
H transferase of RBC membrane from H variants 
was as active as control RBC. 
Such a finding was rather surprising and raised the 
question of a possible deficiency in type 2 chain 
glycolipidic substrate from which the H substance is
built by enzymatic transfer of L-fucose. In order to 
verify this assumption, the UDPGal: GlNAc-/34-D- 
galactosyltransferase ctivities of RBC membrane 
from the H variants (11-2, -3,4; III-l, -2, -3, -5, -6, -8) 
and 3 normal individuals were quantified as described 
in section 2. No difference has been noticed between 
the variants and controls. Indeed the amount of 
D-[ 14C]galactose transfered onto the substrate was 
respectively equal to 44 000 + 4000 cpm/mg protein 
(control RBC) and 47 000 + 8000 cpm/mg protein 
(H variants). 
(iii) The A transferase of all sera is maximally active 
at pH 6.0 which is a property of A1 enzymes 
[25]. In these variants, the A1 antigens are not 
completely developed because only a limited 
amount of H precursor is available. 
The cause of the H antigen decrease in RBC from 
Let. family is not clear since transferases are active as 
measured on low molecular weight acceptors. It was 
shown that H substance r ached anormal evel in 
saliva as estimated by usual 2-fold dilutions assays. 
Obviously, the method does not give a precise quanti- 
tative estimation and it cannot be excluded that H 
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secretion is also affected to some extent. In these 
conditions, the most likely genetical background of 
such phenotypes is the occurence of a rare allele at 
the Hh locus, conveniently named Hm [ 26,271 in 
order to make the difference with the Hz phenotypes 
having a lack of cu-2-Lfucosyltransferase. 
However, the sharp contrast between the normal 
level of H enzyme in Hm RBC and their reduced H 
antigen content does not fit with such a concept and 
it is suggested now, that these variants could be 
explained by a genetic variation not related to the Hh 
locus. Then, either the defect is created in early steps 
of the glycosylation process of carbohydrate chains 
or the H transferase is deprived of substrate by a 
membrane enzyme having an high affinity for the 
2-chain glycolipids. 
These possibilities are under study but if true 
they may signify that the terminology Hm is a 
misnomer. 
The apparent similarity between Am and Hm 
phenotypes established from serological studies [ 141 
is not confirmed by blood group enzyme investiga- 
tions. Indeed, the A transferase of Am sera is only 
30-50% as active as controls [ 191 but is completely 
absent or inactive in RBC [20] which indicates that 
Am phenotypes arise either from a modifier or a rare 
allele at the ABO locus. 
The results obtained bring some information on 
the origin of serum ar-2-L-fucosyltransferase. Indeed, 
when the H antigen is missing%n RBC, no H enzyme 
appears in plasma even if H substance is normally 
secreted in saliva (Hz individuals). Conversely, when 
the H enzyme is expressed on RBC, the H transferase 
is always found in plasma. We have concluded that 
serum cr-2-Lfucosyltransferase mainly originates from 
hematopoietic tissue. 
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